767 related articles for article (PubMed ID: 12042535)
1. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
[TBL] [Abstract][Full Text] [Related]
2. Carrier detection and rapid newborn diagnostic test for the common Y393N maple syrup urine disease allele by PCR-RFLP: culturally permissible testing in the Mennonite community.
Love-Gregory LD; Dyer JA; Grasela J; Hillman RE; Phillips CL
J Inherit Metab Dis; 2001 Jun; 24(3):393-403. PubMed ID: 11486905
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease.
Harris RA; Zhang B; Goodwin GW; Kuntz MJ; Shimomura Y; Rougraff P; Dexter P; Zhao Y; Gibson R; Crabb DW
Adv Enzyme Regul; 1990; 30():245-63. PubMed ID: 2403034
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of branched-chain amino acids in fibroblasts from patients with maple syrup urine disease and other abnormalities of branched-chain ketoacid dehydrogenase activity.
Yoshida I; Sweetman L; Nyhan WL
Pediatr Res; 1986 Feb; 20(2):169-74. PubMed ID: 3080729
[TBL] [Abstract][Full Text] [Related]
6. Classical maple syrup urine disease and brain development: principles of management and formula design.
Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
[TBL] [Abstract][Full Text] [Related]
7. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
8. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
9. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
11. Total parenteral nutrition therapy of toxic maple syrup urine disease.
Townsend I; Kerr DS
Am J Clin Nutr; 1982 Aug; 36(2):359-65. PubMed ID: 6808824
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
Parsons HG; Carter RJ; Unrath M; Snyder FF
J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
[TBL] [Abstract][Full Text] [Related]
13. Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrup urine disease.
Wynn RM; Davie JR; Chuang JL; Cote CD; Chuang DT
J Biol Chem; 1998 May; 273(21):13110-8. PubMed ID: 9582350
[TBL] [Abstract][Full Text] [Related]
14. [Maple syrup urine disease].
Indo Y
Nihon Rinsho; 2002 Apr; 60 Suppl 4():783-7. PubMed ID: 12013999
[No Abstract] [Full Text] [Related]
15. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
Snyderman SE; Goldstein F; Sansaricq C; Norton PM
Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
[TBL] [Abstract][Full Text] [Related]
16. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
18. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease.
Simon E; Fingerhut R; Baumkötter J; Konstantopoulou V; Ratschmann R; Wendel U
J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
